01:43 PM EDT, 06/05/2025 (MT Newswires) -- Health care stocks nudged higher Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.2%.

The iShares Biotechnology ETF (IBB) rose 0.5%.

In corporate news, Johnson & Johnson ( JNJ ) remains focused on its oncology franchise, with a strong drug pipeline to treat cancer and other diseases, as the drugmaker targets to triple oncology sales by 2030, RBC Capital Markets said Thursday. RBC reiterated its outperform rating on the stock with a $181 price target. Johnson & Johnson ( JNJ ) shares were up 0.1%.